This program provides retina specialists and other ophthalmologists caring for patients with neovascular AMD and DME with a comprehensive overview of sustained-release therapies for retinal diseases. Participants will appraise the latest clinical data on the safety and efficacy of sustained delivery platforms, including the Port Delivery System (PDS) with ranibizumab, and emerging options like tyrosine kinase inhibitors and gene therapies. The program will detail the technical consideration...
All content for MedEdicus Podcasts is the property of MedEdicus and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This program provides retina specialists and other ophthalmologists caring for patients with neovascular AMD and DME with a comprehensive overview of sustained-release therapies for retinal diseases. Participants will appraise the latest clinical data on the safety and efficacy of sustained delivery platforms, including the Port Delivery System (PDS) with ranibizumab, and emerging options like tyrosine kinase inhibitors and gene therapies. The program will detail the technical consideration...
Thyroid Eye Disease: Conversations on Comprehensive Comanagement: Diagnosis (CME/CE Podcast) - Part 1
MedEdicus Podcasts
26 minutes
8 months ago
Thyroid Eye Disease: Conversations on Comprehensive Comanagement: Diagnosis (CME/CE Podcast) - Part 1
This podcast, Part 1 of a 3-part series on thyroid eye disease (TED), explores the clinical features of both active and chronic disease, providing a foundation for understanding how to effectively diagnose and manage this condition. Through expert discussions, the faculty review key diagnostic tools and clinical signs, offering insights into the spectrum of TED activity and duration. Listeners will also gain guidance on selecting appropriate treatments tailored to varying stages of disease, p...
MedEdicus Podcasts
This program provides retina specialists and other ophthalmologists caring for patients with neovascular AMD and DME with a comprehensive overview of sustained-release therapies for retinal diseases. Participants will appraise the latest clinical data on the safety and efficacy of sustained delivery platforms, including the Port Delivery System (PDS) with ranibizumab, and emerging options like tyrosine kinase inhibitors and gene therapies. The program will detail the technical consideration...
